臨床試驗

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT：NCT05785832 · COMPLETED

NCT IDNCT05785832

狀態COMPLETED

開始日期2023-06-01

完成時間2024-09-24

SponsorTandem Diabetes Care, Inc. (INDUSTRY)

First posted2023-03-27

Last updated2026-05-22

簡要摘要

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。